Center-Authored Papers

Filters: Author is Andriole, Gerald  [Clear All Filters]
Journal Article
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD et al..  2015.  Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.. Journal of the National Cancer Institute. 107(12) Abstract
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S et al..  2013.  Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.. Human molecular genetics. Abstract
Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC et al..  2014.  Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer.. PLoS genetics. 10(2):e1004129. Abstract
Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S et al..  2014.  Genome-wide association study identifies multiple loci associated with bladder cancer risk.. Human molecular genetics. 23(5):1387-98. Abstract
Eeles RA, Al Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S et al..  2013.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.. Nature genetics. 45(4):385-91,391e1-2. Abstract
Figueroa JD, Middlebrooks CD, Banday RA, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T et al..  2016.  Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.. Human molecular genetics. Abstract
Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L et al..  2014.  Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.. Human molecular genetics. 23(24):6616-33. Abstract
Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC et al..  2013.  A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.. Human molecular genetics. 22(2):408-15. Abstract
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB et al..  2016.  NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(5):509-19. Abstract
Evans CP, Higano CS, Keane T, Andriole G, Saad F, Iversen P, Miller K, Kim C-S, Kimura G, Armstrong AJ et al..  2016.  The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.. European urology. Abstract
Carroll PR, Parsons KJ, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI et al..  2015.  Prostate Cancer Early Detection, Version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(12):1534-61. Abstract
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H et al..  2011.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.. Nature genetics. 43(8):785-791. Abstract
Berndt SI, Wang Z, Yeager M, Alavanja MC, Albanes D, Amundadottir L, Andriole G, Freeman LB, Campa D, Cancel-Tassin G et al..  2015.  Two susceptibility loci identified for prostate cancer aggressiveness.. Nature communications. 6:6889. Abstract